Predictions
TeamViewer AG
Start price
Target price
Perf. (%)
€12.91
22.11.21
22.11.21
€18.00
22.11.22
22.11.22
-4.88%
23.11.22
23.11.22
Could be worthwhile Investment >10% per year
BioNTech SE ADR
Start price
Target price
Perf. (%)
€260.50
21.11.21
21.11.21
€304.00
21.11.22
21.11.22
-37.83%
30.03.22
30.03.22
Could be worthwhile Investment >10% per year
Faurecia S.A.
Start price
Target price
Perf. (%)
€45.93
20.11.21
20.11.21
€43.00
20.11.22
20.11.22
-10.95%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Royal Mail plc
Start price
Target price
Perf. (%)
€5.93
19.11.21
19.11.21
-
19.11.22
19.11.22
-2.70%
10.12.21
10.12.21
Probably not worthwhile Investment
Elis Services S.A.
Start price
Target price
Perf. (%)
€15.31
18.11.21
18.11.21
€14.50
08.05.22
08.05.22
-2.48%
22.11.21
22.11.21
Could be worthwhile Investment >10% per year
Eurofins Scientific SE
Start price
Target price
Perf. (%)
€106.52
17.11.21
17.11.21
€100.00
17.11.22
17.11.22
6.67%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€112.05
17.11.21
17.11.21
€120.00
17.11.22
17.11.22
-33.42%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
High valuation
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€152.65
16.11.21
16.11.21
€200.00
31.01.25
31.01.25
36.59%
03.08.22
03.08.22
Could be worthwhile Investment >10% per year
Sociedad Quimica y Minera de Chile SA ADR
Start price
Target price
Perf. (%)
€56.00
16.11.21
16.11.21
-
16.11.25
16.11.25
-25.00%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
BioNTech SE ADR
Start price
Target price
Perf. (%)
€222.70
16.11.21
16.11.21
€250.00
16.11.22
16.11.22
-18.12%
13.01.22
13.01.22
Significant cyclical dependencies
BioNTech SE ADR
Start price
Target price
Perf. (%)
€212.70
15.11.21
15.11.21
€170.00
15.11.22
15.11.22
-35.14%
28.04.22
28.04.22
Good rating
Medium risks for its business
Very low/no dividend yield expected
high free float
Amarin Corp. ADR
Start price
Target price
Perf. (%)
€3.40
15.11.21
15.11.21
€2.00
31.12.23
31.12.23
-15.88%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Commerzbank AG
Start price
Target price
Perf. (%)
€7.09
15.11.21
15.11.21
-
15.11.22
15.11.22
-7.31%
06.12.21
06.12.21
Risky Investment
Revenue decline > 20% expected
New Oriental Education & Technology Group
Start price
Target price
Perf. (%)
€1.84
15.11.21
15.11.21
-
15.11.22
15.11.22
2.17%
27.11.21
27.11.21
Risky Investment
New Oriental Education & Technology Group ADR
Start price
Target price
Perf. (%)
€19.20
15.11.21
15.11.21
-
15.11.22
15.11.22
1.56%
27.11.21
27.11.21
Risky Investment
TAL Education Group ADR
Start price
Target price
Perf. (%)
€3.64
15.11.21
15.11.21
-
15.11.22
15.11.22
20.88%
27.11.21
27.11.21
Risky Investment
Sociedad Quimica y Minera de Chile SA ADR
Start price
Target price
Perf. (%)
€58.20
15.11.21
15.11.21
€70.00
15.11.22
15.11.22
-3.78%
27.11.21
27.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
BioNTech SE ADR
Start price
Target price
Perf. (%)
€210.00
14.11.21
14.11.21
€185.00
14.11.22
14.11.22
-25.98%
15.11.22
15.11.22
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€16.30
14.11.21
14.11.21
€10.00
14.11.22
14.11.22
-62.67%
15.11.22
15.11.22
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
ROE lower than 10% per year
Encavis AG
Start price
Target price
Perf. (%)
€17.99
14.11.21
14.11.21
€19.70
14.11.22
14.11.22
-9.01%
28.11.21
28.11.21
Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€199.52
14.11.21
14.11.21
€230.00
14.11.22
14.11.22
-19.81%
18.03.22
18.03.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€13.55
13.11.21
13.11.21
-
13.11.22
13.11.22
-69.88%
14.11.22
14.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Cronos Group Inc.
Start price
Target price
Perf. (%)
€5.39
13.11.21
13.11.21
-
07.11.25
07.11.25
-56.42%
02.06.24
02.06.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model